Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 95
Filter
1.
Eur J Clin Microbiol Infect Dis ; 41(11): 1337-1345, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36181564

ABSTRACT

Selective decontamination of the digestive tract (SDD) is aimed at elimination of potential pathogenic microorganisms. In this study, the effect of SDD on gut microbiota was evaluated in a large homogenous group of elective colorectal cancer surgery patients. Rectal swabs were taken from 118 patients undergoing colorectal surgery. These patients were randomly assigned to receive perioperative SDD or to the control group (no SDD). Rectal swabs were taken prior to surgery, 3 days after commencing administration of SDD. Gut microbial profiles were obtained with the IS-pro technique, a standardized microbiota profiling assay applicable in clinical routine. Differences in abundance for different taxonomical groups and diversity between the groups were assessed. Unsupervised and supervised classification techniques were used to assess microbial signatures, differentiating between the SDD group and the control group. Patients in the SDD group had different gut microbial signatures than in the control group, also in phyla that are not a target for SDD. Escherichia coli, Sutterella spp., Faecalibacterium prausnitzii, and Streptococcus spp. were the species that differed the most between the two groups. The SDD group showed clustering into two subgroups. In one subgroup, a decrease in Proteobacteria was observed, whereas the other subgroup showed a shift in Proteobacteria species. This study shows that SDD not only decreases colonization of the gastrointestinal tract with potential pathogenic Gram-negative microorganisms, but also reduces the abundance of normal colonizers of our gastrointestinal system and leads to a shift in total microbiota composition.


Subject(s)
Gastrointestinal Microbiome , Anti-Bacterial Agents/therapeutic use , Decontamination/methods , Elective Surgical Procedures/methods , Gastrointestinal Tract/microbiology , Humans , Intensive Care Units
2.
Br J Surg ; 106(4): 355-363, 2019 03.
Article in English | MEDLINE | ID: mdl-30802304

ABSTRACT

BACKGROUND: Infectious complications and anastomotic leakage affect approximately 30 per cent of patients after colorectal cancer surgery. The aim of this multicentre randomized trial was to investigate whether selective decontamination of the digestive tract (SDD) reduces these complications of elective colorectal cancer surgery. METHODS: The effectiveness of SDD was evaluated in a multicentre, open-label RCT in six centres in the Netherlands. Patients with colorectal cancer scheduled for elective curative surgery with a primary anastomosis were eligible. Oral colistin, tobramycin and amphotericin B were administered to patients in the SDD group to decontaminate the digestive tract. Both treatment and control group received intravenous cefazolin and metronidazole for perioperative prophylaxis. Mechanical bowel preparation was given for left-sided colectomies, sigmoid and anterior resections. Anastomotic leakage was the primary outcome; infectious complications and mortality were secondary outcomes. RESULTS: The outcomes for 228 patients randomized to the SDD group and 227 randomized to the control group were analysed. The trial was stopped after interim analysis demonstrated that superiority was no longer attainable. Effective SDD was confirmed by interspace DNA profiling analysis of rectal swabs. Anastomotic leakage was observed in 14 patients (6·1 per cent) in the SDD group and in 22 patients (9·7 per cent) in the control group (odds ratio (OR) 0·61, 95 per cent c.i. 0·30 to 1·22). Fewer patients in the SDD group had one or more infectious complications than patients in the control group (14·9 versus 26·9 per cent respectively; OR 0·48, 0·30 to 0·76). Multivariable analysis indicated that SDD reduced the rate of infectious complications (OR 0·47, 0·29 to 0·76). CONCLUSION: SDD reduces infectious complications after colorectal cancer resection but did not significantly reduce anastomotic leakage in this trial. Registration number: NCT01740947 ( https://www.clinicaltrials.gov).


Subject(s)
Colectomy/methods , Colorectal Neoplasms/surgery , Decontamination/methods , Elective Surgical Procedures/methods , Surgical Wound Infection/prevention & control , Academic Medical Centers , Aged , Analysis of Variance , Anastomosis, Surgical/methods , Antibiotic Prophylaxis , Colectomy/adverse effects , Colorectal Neoplasms/pathology , Elective Surgical Procedures/adverse effects , Female , Follow-Up Studies , Hospitals, University , Humans , Male , Middle Aged , Multivariate Analysis , Netherlands , Preoperative Care/methods , Reference Values , Risk Assessment , Tobramycin/administration & dosage , Treatment Outcome
3.
Gen Thorac Cardiovasc Surg ; 67(1): 154-160, 2019 Jan.
Article in English | MEDLINE | ID: mdl-28852959

ABSTRACT

Dissection of the descending aorta is a serious and potentially lethal event. Treatment options consist of medical therapy, open surgical replacement of the affected aorta and thoracic endovascular repair. In acute cases, medical treatment is started initially. When complicated, endovascular repair is generally considered as first choice treatment, except for connective tissue disorders where open surgery remains the standard. In stable, uncomplicated patients with risk factors for future aortic growth pre-emptive endovascular repair should be considered in the sub-acute phase of the dissection. The treatment strategy in chronic dissections is somewhat debated. Long-term results and aortic remodeling of endovascular repair are disappointing and open surgery remains the standard.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Endovascular Procedures/methods , Aorta/surgery , Blood Vessel Prosthesis Implantation , Disease Management , Humans , Patient Selection , Risk Factors , Treatment Outcome
4.
Ned Tijdschr Geneeskd ; 162: D2294, 2018.
Article in Dutch | MEDLINE | ID: mdl-29676710

ABSTRACT

OBJECTIVE: To determine the effect of radical prostatectomy (RP) hospital volume on the probability of post-RP incontinence. DESIGN: Retrospective research based on claims-based data of health insurers. METHOD: For every patient with RP the probability of incontinence was determined, based on the definition of claims of one or more incontinence pads per day. Casemix corrections were made based on indicators available in claims-data: age, lymph node dissection, and radiotherapy. No casemix corrections could be made for tumour stage and surgical technique. RESULTS: A total of 1590 patients were included in this study; for 26.0% of these patients, an average of one or more incontinence pads per day were claimed for. A significant relation between the volume of RP per hospital and the claims of incontinence material was observed. The probability of incontinence was significantly lower in hospitals with a volume of more than 100 RP patients per year when compared to hospitals with less than 100 RP patients per year. CONCLUSION: The probability of post-RP incontinence decreases as hospitals conduct more RP procedures. The casemix factors included in the analysis only had a limited impact on this observation.


Subject(s)
Incontinence Pads , Prostatectomy/adverse effects , Prostatic Neoplasms/surgery , Urinary Incontinence , Aged , Humans , Incidence , Incontinence Pads/economics , Incontinence Pads/statistics & numerical data , Insurance Claim Review/statistics & numerical data , Male , Middle Aged , Netherlands/epidemiology , Prostatectomy/methods , Retrospective Studies , Urinary Incontinence/economics , Urinary Incontinence/epidemiology , Urinary Incontinence/etiology
5.
JMM Case Rep ; 3(4): e005035, 2016 Aug.
Article in English | MEDLINE | ID: mdl-28348765

ABSTRACT

INTRODUCTION: Diagnosing progressive disseminated histoplasmosis (PDH) in patients with systemic lupus erythematosus (SLE) is diagnostically challenging. Since PDH is lethal when untreated, awareness of this infection in patients with SLE is of utmost importance. To the best of our knowledge, this is the first description of a case of PDH in a patient with SLE in Europe. CASE PRESENTATION: A 56-year-old woman of Surinamese descent with a history of SLE, presented with fever and polyarthritis. Although a flare of SLE was suspected initially, cultures of bone marrow and broncho-alveolar lavage fluid grew Histoplasma capsulatum. CONCLUSION: This case report highlights that physicians should be aware of progressive disseminated histoplasmosis in patients with SLE treated with immunosuppressive agents. The signs and symptoms can easily mimic a SLE flare, which would then be treated with more aggressive immunosuppression. Failure to recognize the infection will therefore invariably lead to death of the patient. Progressive disseminated histoplasmosis is usually not recognized by doctors in non-endemic areas such as Europe. However, globalisation and more frequent intercontinental traffic of immunocompromised patients currently increases the incidence of histoplasmosis in these areas. It is therefore of life-saving importance that doctors are aware of the features of the infection in areas where H. capsulatum is not endemic.

7.
Neth Heart J ; 20(3): 132, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22322585
8.
Neth Heart J ; 18(7-8): 376-7, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20730007

ABSTRACT

We describe the finding of an aortic aneurysm in an asymptomatic 43-year-old male, who was managed by Dacron patch aortoplasty for native coarctation of the aorta 25 years before. The role of magnetic resonance angiography as standard imaging technique in lifelong postoperative surveillance is discussed subsequently. (Neth Heart J 2010;18:376-7.).

9.
Neth Heart J ; 18(4): 209-11, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20428420

ABSTRACT

A sinus of Valsalva aneurysm is a rare cardiac anomaly that may be congenital or acquired; a coexisting cardiac lesion might be present. If the aneurysm ruptures, it causes acute symptoms of dyspnoea. Echocardiography and cardiac magnetic resonance imaging are useful for diagnosis. The treatment of choice is surgery. We present a case of a patient with acute onset of symptoms due to a ruptured sinus of Valsalva aneurysm. (Neth Heart J 2010;18:209-11.).

10.
Eur J Vasc Endovasc Surg ; 37(6): 640-5, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19362499

ABSTRACT

OBJECTIVES: The aim of this study is to report our experience in the surgical repair of thoracoabdominal aortic aneurysms (TAAAs) over the last 27 years against the background of evolving surgical techniques. METHODS: We reviewed the prospectively collected data of 571 patients who underwent open TAAA repair between 1981 and 2008. Data were analysed using univariate and multivariate analysis (logistic regression). Pre-, intra- and postoperative risk factors were used to develop risk models for in-hospital mortality, spinal cord deficit and renal failure. Recent published series were used to highlight the different treatment modalities and explore results. RESULTS: Seventy patients (12.3%) died in the hospital, the 30-day mortality was 8.9%, 37 patients (6.5%) required postoperative dialysis and 47 patients (8.3%) developed paraplegia or paraparesis. The incidence of paraplegia in the left heart bypass group was 4.4%. The predictors for hospital mortality were increasing age (odds ratio 1.096 per year, 95% confidence interval (CI): 1.05-1.14) and the need for haemodialysis (odds ratio 10, 95% CI: 4.7-21.1). For postoperative spinal cord deficit, we found three protecting factors: age above 75 years (odds ratio 0.14, 95% CI: 0.19-1.09), the presence of a post-dissection aneurysm (odds ratio 0.4, 95% CI: 0.17-0.94) and the combined use of cerebrospinal fluid drainage and motor-evoked potentials (odds ratio 0.28, 95% CI: 0.14-0.56). The urgency of procedure (odds ratio 4, 95% CI: 1.8-9) and preoperative serum creatinine level (odds ratio 1.007 per micromole per litre, 95% CI: 1.0-1.01) were significant risk factors for renal failure. CONCLUSIONS: Open TAAA repair intrinsically has substantial complications, of which spinal cord ischaemia and renal failure are the most devastating, despite major progress in our understanding of the pathophysiology and operative strategy. An overview of the results of recently published series is given along with an analysis of our data.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Aortic Dissection/surgery , Renal Insufficiency/etiology , Spinal Cord Ischemia/etiology , Vascular Surgical Procedures/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Aortic Dissection/mortality , Aortic Aneurysm, Thoracic/mortality , Female , Hospital Mortality , Humans , Logistic Models , Male , Middle Aged , Odds Ratio , Paraparesis/etiology , Paraplegia/etiology , Prospective Studies , Renal Dialysis , Renal Insufficiency/mortality , Renal Insufficiency/therapy , Risk Assessment , Risk Factors , Spinal Cord Ischemia/mortality , Time Factors , Treatment Outcome , Vascular Surgical Procedures/mortality , Young Adult
11.
Neurology ; 72(15): 1322-9, 2009 Apr 14.
Article in English | MEDLINE | ID: mdl-19365053

ABSTRACT

OBJECTIVE: Axonal degeneration is the likely cause of disease progression in multiple sclerosis (MS). Our previous results indicated that neuron-specific N-acetylaspartate (NAA) is a candidate CSF biomarker for disease progression in MS. The aim of this study was to explore the potential of NAA as an early biomarker of axonal damage in MS. Next, we wanted to know the additional value of measurement of NAA compared to other candidate markers for axonal damage, such as neurofilament subunits and tau protein. METHODS: Levels of NAA, neurofilament light, neurofilament heavy, and tau were determined in CSF of patients with clinically isolated syndrome (CIS, n = 38), relapsing-remitting MS (RRMS, n = 42), secondary progressive MS (SPMS, n = 28), and primary progressive MS (PPMS, n = 6); patients without neurologic disease (ND, n = 28); noninflammatory neurologic controls (n = 18); and inflammatory neurologic controls (n = 39). RESULTS: CSF NAA levels were decreased in patients with SPMS compared to ND controls, patients with CIS, and patients with RRMS. CSF NAA levels in patients with CIS and RRMS were similar to those in ND subjects. All axonal damage proteins showed specific patterns of changes and relations with disease activity measures. The neurofilament light chain levels were already increased in patients with CIS, especially in patients who converted to MS. The neurofilament heavy chain levels were highest in the patients with SPMS. Tau levels were similar in MS and ND. CONCLUSIONS: CSF N-acetylaspartate (NAA) levels were not different from patients without neurologic disease in early stages of multiple sclerosis, though decreased as the disease progressed. Combining CSF NAA and neurofilament levels yields information on different phases of axonal pathology.


Subject(s)
Aspartic Acid/analogs & derivatives , Multiple Sclerosis/cerebrospinal fluid , Neurofilament Proteins/cerebrospinal fluid , Amino Acids/cerebrospinal fluid , Aspartic Acid/cerebrospinal fluid , Axons/pathology , Biomarkers , Cohort Studies , Disease Progression , Humans , Magnetic Resonance Imaging , Multiple Sclerosis/pathology , Multiple Sclerosis, Chronic Progressive/cerebrospinal fluid , Multiple Sclerosis, Chronic Progressive/pathology , Multiple Sclerosis, Relapsing-Remitting/cerebrospinal fluid , Multiple Sclerosis, Relapsing-Remitting/pathology , Nerve Degeneration/pathology , tau Proteins/cerebrospinal fluid
12.
J Cardiovasc Surg (Torino) ; 50(1): 55-62, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19179991

ABSTRACT

In the absence of randomized trials, the optimal management of patients with concomitant carotid and coronary artery disease remains disputable. The initial studies of combined or staged carotid endarterectomy in these patients were conceived in an attempt to reduce perioperative mortality. Although encouraging results have been reported with combined carotid endarterectomy and cardiac surgery, this combination requires long operative times and remains a surgical challenge. Recent studies have shown that carotid angioplasty and stenting prior to cardiac surgery is a feasible and effective minimal invasive technique. However, the effect of carotid stenting on the incidence of death and stroke after cardiac surgery is indistinct. Carotid stenting followed by cardiac surgery may provide a valuable treatment for patients with combined carotid and cardiac disease. The high rate of freedom from death and stroke during follow-up supports the long-term durability of this strategy. In the present review, we highlight the available data on carotid stenting and cardiac surgery.


Subject(s)
Angioplasty/instrumentation , Carotid Artery Diseases/surgery , Coronary Artery Bypass , Coronary Artery Disease/surgery , Endarterectomy, Carotid , Stents , Stroke/prevention & control , Angioplasty/adverse effects , Angioplasty/mortality , Carotid Artery Diseases/complications , Carotid Artery Diseases/mortality , Coronary Artery Bypass/adverse effects , Coronary Artery Disease/complications , Coronary Artery Disease/mortality , Endarterectomy, Carotid/adverse effects , Endarterectomy, Carotid/mortality , Humans , Myocardial Infarction/etiology , Myocardial Infarction/prevention & control , Patient Selection , Platelet Aggregation Inhibitors/therapeutic use , Practice Guidelines as Topic , Risk Assessment , Severity of Illness Index , Stroke/etiology , Stroke/mortality , Time Factors , Treatment Outcome
13.
Eur J Vasc Endovasc Surg ; 36(4): 379-84, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18620876

ABSTRACT

In the absence of randomized trials, the optimal management of patients who present with concomitant carotid and coronary artery disease remains an enduring controversy, with much of the debate revolving around whether staged or synchronous carotid endarterectomy (CEA) will reduce peri-operative morbidity and mortality after cardiac surgery. Although encouraging results have been reported using either strategy, there remains no consensus as to which is preferable. More recently, however, carotid artery angioplasty with stenting (CAS) has emerged as a potential alternative to CEA. In 'high-risk for CEA' patients, CAS has shown comparable short and long-term outcome rates to CEA. Accordingly, CAS followed by cardiac surgery could offer a less invasive (and safer) therapeutic option in cardiac patients. This paper reviews the evidence to date supporting the use of CAS+CABG, while highlighting potential situations where such a strategy might be harmful. In particular, it will focus on how the need for dual antiplatelet therapy after CAS can be balanced with avoiding unnecessary bleeding complications after cardiac surgery.


Subject(s)
Angioplasty, Balloon , Coronary Artery Bypass , Endarterectomy, Carotid , Stents , Carotid Stenosis/complications , Carotid Stenosis/surgery , Coronary Artery Disease/complications , Coronary Artery Disease/surgery , Humans
14.
Acta Chir Belg ; 108(2): 244-6, 2008.
Article in English | MEDLINE | ID: mdl-18557152

ABSTRACT

This report describes a one-stage treatment of a 30-year-old patient suffering from severe aortic valve insufficiency, aortic co-arctation, dilatation of the ascending aorta and arcus hypoplasia. The patient underwent aortic valve, ascending aorta and arch replacement through median sternotomy. The aorta was ligated at the level of the co-arctation, which was located in the proximal part of the descending aorta, and an ascending-descending bypass was created using a transhiatic approach. The postoperative course was complicated by a cerebrovascular accident.


Subject(s)
Aorta, Thoracic/surgery , Aortic Aneurysm/surgery , Aortic Coarctation/surgery , Aortic Valve Insufficiency/surgery , Cardiovascular Surgical Procedures/methods , Adult , Aorta, Thoracic/abnormalities , Humans , Male
15.
Cytogenet Genome Res ; 118(2-4): 157-65, 2007.
Article in English | MEDLINE | ID: mdl-18000366

ABSTRACT

Renal cell carcinomas (RCCs) represent a heterogeneous group of neoplasms, which differ in histological, pathologic and clinical characteristics. The tumors originate from different locations within the nephron and are accompanied by different recurrent (cyto)genetic anomalies. Recently, a novel subgroup of RCCs has been defined, i.e., the MiT translocation subgroup of RCCs. These tumors originate from the proximal tubule of the nephron, exhibit pleomorphic histological features including clear cell morphologies and papillary structures, and are found predominantly in children and young adults. In addition, these tumors are characterized by the occurrence of recurrent chromosomal translocations, which result in disruption and fusion of either the TFE3 or TFEB genes, both members of the MiT family of basic helix-loop-helix/leucine-zipper transcription factor genes. Hence the name MiT translocation subgroup of RCCs. In this review several features of this RCC subgroup will be discussed, including the molecular mechanisms that may underlie their development.


Subject(s)
Carcinoma, Renal Cell/genetics , Kidney Neoplasms/genetics , Translocation, Genetic , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Carcinoma, Renal Cell/pathology , Gene Fusion , Humans , Kidney Neoplasms/pathology , Neoplasm Proteins/genetics
16.
Neuroscience ; 147(3): 811-23, 2007 Jul 13.
Article in English | MEDLINE | ID: mdl-17574765

ABSTRACT

A prolonged period of waking accumulates sleep pressure, increasing both the duration and the intensity of the subsequent sleep period. Delta power, which is calculated from the slow range electroencephalographic (EEG) oscillations (0.1-4 Hz), is regarded as the marker of sleep intensity. Recent findings indicate that not only the duration but also the quality of waking, determines the level of increase in the delta activity during the subsequent sleep period. Elevated levels of extracellular adenosine in the basal forebrain (BF) during prolonged waking have been proposed to act as the molecular signal of increased sleep pressure, but the role of BF neuronal activity in elevating adenosine has not been previously explored. We hypothesized that an increase in neuronal discharge in the BF would lead to increase in the extracellular adenosine and contribute to the increase in the subsequent sleep. To experimentally increase neuronal activity in the rat BF, we used 3 h in vivo microdialysis application of glutamate or its receptor agonists N-methyl-D-aspartate (NMDA) or AMPA. Samples for adenosine measurement were collected during the drug application and the EEG was recorded during and after the treatment, altogether for 24 h. All treatments increased the duration of the subsequent sleep following the application. In contrast, delta power was elevated only if both the waking EEG theta (5-9 Hz) power (which can be regarded as a marker of active waking) and the extracellular adenosine in the BF were increased during the application. These results indicate that increased neuronal activity in the BF, and particularly the type of neuronal activity coinciding with active waking, is one of the factors contributing to the buildup of the sleep pressure.


Subject(s)
Adenosine/metabolism , Extracellular Fluid/drug effects , Glutamic Acid/pharmacology , Prosencephalon/cytology , Sleep/drug effects , Animals , Chromatography, High Pressure Liquid , Dizocilpine Maleate/pharmacology , Electroencephalography/methods , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Extracellular Fluid/metabolism , Male , Microdialysis/methods , Oncogene Proteins v-fos/metabolism , Polysomnography , Rats , Rats, Wistar
18.
Eur J Vasc Endovasc Surg ; 34(2): 169-72, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17408991

ABSTRACT

OBJECTIVES: Thoracic endovascular aortic repair is associated with postoperative spinal cord ischemia in approximately 1 to 12.5% of all cases. S100beta is a protein that is released during acute damage of the central nervous system. This study was performed to determine the concentration of S100beta in cerebrospinal fluid during and after stenting of the thoracic aorta in patients at high risk for spinal cord ischemia. DESIGN: Prospective clinical study. MATERIALS AND METHODS: Eight patients who underwent elective thoracic aortic stent grafting underwent lumbar spinal fluid drainage. These patients were at high risk to develop spinal cord ischemia. METHODS: CSF samples for analysis of S100beta protein were drawn after induction of anesthesia, during stenting, once every hour the following six hours and 20 hours after repair. RESULTS: No significant increase in S100beta protein could be detected in CSF and no neurological deficits were detected postoperatively. CONCLUSIONS: The results of this study show us that there is no significant release of S100beta protein in CSF during stenting of the thoracic aorta in this subgroup of patients at high risk for spinal cord ischemia, consistent with clinical exam that there was no significant damage to the central nervous system.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Blood Vessel Prosthesis Implantation/adverse effects , Nerve Growth Factors/cerebrospinal fluid , S100 Proteins/cerebrospinal fluid , Spinal Cord Ischemia/etiology , Stents , Aged , Aortic Aneurysm, Thoracic/cerebrospinal fluid , Biomarkers/cerebrospinal fluid , Blood Vessel Prosthesis Implantation/instrumentation , Female , Humans , Male , Middle Aged , Prospective Studies , Risk Assessment , S100 Calcium Binding Protein beta Subunit , Spinal Cord Ischemia/cerebrospinal fluid , Treatment Outcome
20.
Ned Tijdschr Geneeskd ; 150(10): 554-8, 2006 Mar 11.
Article in Dutch | MEDLINE | ID: mdl-16566420

ABSTRACT

A 64-year-old man who was evaluated for a long history of a discontinuous barking cough with difficulty in coughing up sputum was found to have 90% stenosis of the trachea. Further imaging studies revealed a right-sided descending aorta with an aberrant left subclavian artery arising from a Kommerell diverticulum. This caused the compression of the trachea. The compression was relieved by transposition of the aberrant left subclavian artery to the ascending aorta and replacement of the aneurysmatic part of the aorta by an endoprosthesis.


Subject(s)
Aorta, Thoracic/abnormalities , Diverticulum/complications , Subclavian Artery/abnormalities , Tracheal Stenosis/etiology , Aorta, Thoracic/surgery , Blood Vessel Prosthesis , Diverticulum/surgery , Humans , Male , Middle Aged , Subclavian Artery/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...